Key result
Laparoscopic sleeve gastrectomy effectively treated metabolic syndrome components and obesity-related comorbidities, and improved inflammatory, kidney, and liver biomarkers at 1-year follow-up.
Why the study?
To assess the efficiency of laparoscopic sleeve gastrectomy in resolving metabolic syndrome components, treating comorbidities, and influencing biochemical markers.
Does laparoscopic sleeve gastrectomy improve metabolic syndrome components and biochemical markers in patients with morbid obesity?
Population
211 patients after a laparoscopic sleeve gastrectomy operation
Comparison
Laparoscopic sleeve gastrectomy (single-arm cohort)
Design
Retrospective cohort study
Follow-up
1-year
Authors
Loading...
Metabolic surgery was associated with MS improvement in obesity; leaves open need for RCTs to guide practice.
Cohort (n=211)
Does laparoscopic sleeve gastrectomy improve metabolic syndrome components and biochemical markers in patients with morbid obesity?
Laparoscopic sleeve gastrectomy effectively treats metabolic syndrome components and improves inflammatory, kidney, and liver biomarkers at 1-year follow-up.
Wójciak et al. (2019) conducted a cohort in Metabolic syndrome and morbid obesity (n=211). Laparoscopic sleeve gastrectomy was evaluated on Resolution of metabolic syndrome components, comorbidities, and biochemical markers. Laparoscopic sleeve gastrectomy effectively treated metabolic syndrome components and obesity-related comorbidities, and improved inflammatory, kidney, and liver biomarkers at 1-year follow-up.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: